Dr. Jeff Geschwind’s UAE Research A New Era in Fibroid Management

(Alees Albert) #1

Diagnostics Diagnostics 20252025 , (^15) , 15 , 739, x FOR PEER REVIEW 8 of 13 7 of 12
Figure 4. Clinical symptoms and QoL measures before and after UAE by age group: less than 45
years of age ( A ), between 45 and 55 years of age ( B ) and over 55 years of age ( C ). The over 55 age
group had a better mean score than the under 45 and 45–55 age groups for symptoms and all QoL
measures before treatment ( p -value < 0.001 in all cases). After treatment, the mean score of the over
55 group remained better than the other two age groups; however, after UAE, the disparity between
the age groups was reduced, and for most measures, the disparity lost its statistical significance.
(Triple asterisks indicate p -value < 0.001.)
Figure 4. Clinical symptoms and QoL measures before and after UAE by age group: less than45 years
of age ( A ), between 45 and 55 years of age ( B ) and over 55 years of age ( C ). The over 55 age group
had a better mean score than the under 45 and 45–55 age groups for symptoms and all QoL measures
before treatment (p-value < 0.001 in all cases). After treatment, the mean score of the over55 group
remained better than the other two age groups; however, after UAE, the disparity between the age
groups was reduced, and for most measures, the disparity lost its statistical significance. (Triple
asterisks indicatep-value < 0.001.)


The location of the fibroids did not have any correlation with the QoL of the patients


either before or after treatment. On the other hand, the type of fibroid (submucosal, sub-

serosal, or intramural) did have a significant effect on patients’ clinical symptoms and most


QoL measures (all ANOVAp-values < 0.05, except for the control). More specifically, before


treatment, patients with submucosal fibroids had significantly worse QoL measures and ex-


perienced the most severe clinical symptoms (bothp-values < 0.01). After UAE, differences


between the submucosal and the other two fibroid types were not statistically significant
both in terms of symptoms and QoL measures. Thus, post-UAE, the type of fibroids had

no bearing on any of the clinical symptoms (p-value > 0.05 for all four categories).


The UAE procedures, which were performed in various OBL locations mostly in the
northeast of the US, followed a standardized technique but did not mandate a specific

arterial access between the common femoral and radial artery. The fluoroscopy time of the


procedure, which was captured as part of the electronic medical records (EMRs) revealed
that procedures performed through a femoral access took longer by almost 3 min than

those performed through the radial artery (mean of 10 vs. 7 min,p< 0.001).


The presence or absence of clinical symptoms captured on the EMR in a binary fashion


included menorrhagia, menometrorrhagia, blood clots, and pelvic pain. Resolution of these


symptoms post-UAE was statistically significant (p< 0.001) (Figure 6).

Free download pdf